The European Commission awards its 50th European Industrial Doctorate (EID) research grant. The €1.5 million grant is for research into new antibodies that will destroy a tumour's blood vessels and eradicate the tumour. The so-called VAMPIRE project ('Vascular Antibody-Mediated Pharmaceutically Induced tumour Resection') is led by the University of Birmingham in the UK and SomantiX, a Dutch biotech company based in Utrecht.
